Abstract

Prolonged Partial Response to Bevacizumab and Valproic Acid in a Patient With Glioblastoma.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Valproic acid enhances etoposide induced cytotoxicity in neuroblastoma cells
D G Aguilera ... P Zage
Journal of Clinical Oncology | VOL. 25
D G Aguilera, et. al.D G Aguilera ... P Zage
20 Jun 2007
Results of a phase 2 study of valproic acid alone or in combination with all-trans retinoic acid in 75 patients with myelodysplastic syndrome and relapsed or refractory acute myeloid leukemia
Andrea Kuendgen ... Sabine Knipp
Annals of hematology | VOL. 84
Andrea Kuendgen, et. al.Andrea Kuendgen ... Sabine Knipp
04 Nov 2005
Corticosteroid Therapy in the Age of Infliximab: Acute and 1-Year Outcomes in Newly Diagnosed Children With Crohn’s Disease
James Markowitz ...
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association | VOL. 4
James Markowitz, et. al.James Markowitz ...
24 Jul 2006
Phase I trial of a sequence-specific combination of the HDAC inhibitor, valproic acid (VPA), and the topoisomerase II inhibitor, epirubicin, in advanced solid tumors: Clinical results and correlative studies
P N Munster ... M L Schmitt
Journal of Clinical Oncology | VOL. 24
P N Munster, et. al.P N Munster ... M L Schmitt
20 Jun 2006
View more papers

More From: JCO Precision Oncology

Paper Title
Journal
Date
Author
Improving Access to Hereditary Testing in Pancreatic Ductal Carcinoma.
Carol Cremin ... Kasmintan A Schrader
JCO Precision Oncology | VOL. 8
Carol Cremin, et. al.Carol Cremin ... Kasmintan A Schrader
01 Aug 2024
Molecular Differences With Therapeutic Implications in Early-Onset Compared With Average-Onset Biliary Tract Cancers.
Thejus Jayakrishnan ... Alok A Khorana
JCO Precision Oncology | VOL. 8
Thejus Jayakrishnan, et. al.Thejus Jayakrishnan ... Alok A Khorana
01 Aug 2024
Landscape of Concomitant Driver Alterations in Classical EGFR-Mutated Non-Small Cell Lung Cancer.
Huaying Wang ... Renhua Guo
JCO Precision Oncology | VOL. 8
Huaying Wang, et. al.Huaying Wang ... Renhua Guo
01 Aug 2024
Germline Susceptibility to Renal Cell Carcinoma and Implications for Genetic Screening.
Kate I Glennon ... Yasser Riazalhosseini
JCO Precision Oncology | VOL. 8
Kate I Glennon, et. al.Kate I Glennon ... Yasser Riazalhosseini
01 Jul 2024
View more papers